Literature DB >> 12439806

Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection.

Oluwatoyin Falusi1, Audrey L French, Eric C Seaberg, Phyllis C Tien, D Heather Watts, Howard Minkoff, Eva Piessens, Andrea Kovacs, Kathryn Anastos, Mardge H Cohen.   

Abstract

We assessed the prevalence and predictors of latent Toxoplasma infection in a large group of human immunodeficiency virus (HIV)-infected and HIV-uninfected at-risk US women. The prevalence of latent Toxoplasma infection was 15% (380 of 2525 persons) and did not differ by HIV infection status. HIV-infected women aged > or =50 years and those born outside of the United States were more likely to have latent Toxoplasma infection, with prevalences of 32% and 41%, respectively.

Entities:  

Mesh：

Year:  2002        PMID： 12439806      PMCID： PMC3119037          DOI： 10.1086/344462

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis.

Authors:  I Reiter-Owona; E Petersen; D Joynson; H Aspöck; M L Dardé; R Disko; O Dreazen; H Dumon; R Grillo; U Gross; M Hayde; R Holliman; D O Ho-Yen; K Janitschke; P A Jenum; K Naser; M Olszewski; P Thulliez; H M Seitz
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

2.  A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. VI. TOXOPLASMA ANTIBODIES.

Authors:  H A FELDMAN
Journal:  Am J Epidemiol       Date:  1965-05       Impact factor: 4.897

3.  Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965.

Authors:  K L Smith; M Wilson; A W Hightower; P W Kelley; J P Struewing; D D Juranek; J B McAuley
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

4.  Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease.

Authors:  R Ruiz; S Cu-Uvin; T Fiore; T P Flanigan
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

Review 5.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

6.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

7.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

8.  Vertical transmission of toxoplasma by human immunodeficiency virus-infected women.

Authors:  H Minkoff; J S Remington; S Holman; R Ramirez; S Goodwin; S Landesman
Journal:  Am J Obstet Gynecol       Date:  1997-03       Impact factor: 8.661

9.  Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.

Authors:  S B Porter; M A Sande
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

10.  Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers.

Authors:  B Wong; J W Gold; A E Brown; M Lange; R Fried; M Grieco; D Mildvan; J Giron; M L Tapper; C W Lerner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391
View more
  18 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Toxoplasma gondii infection in hospitalized people living with HIV in Spain, 1997 to 2015.

Authors:  Marouane Menchi-Elanzi; Asunción M Mayoral; Javier Morales; Hector Pinargote-Celorio; Gregorio González-Alcaide; José-Manuel Ramos-Rincón
Journal:  Parasitol Res       Date:  2021-01-14       Impact factor: 2.289

3.  Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.

Authors:  E G Lago; G S Conrado; C S Piccoli; R L Carvalho; A L Bender
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

4.  Toxoplasmosis during pregnancy: a case report and review of the literature.

Authors:  C Giannoulis; B Zournatzi; A Giomisi; E Diza; I Tzafettas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

5.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

6.  Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Imtiaz A Khan
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

7.  Trends, productivity losses, and associated medical conditions among toxoplasmosis deaths in the United States, 2000-2010.

Authors:  Patricia L Cummings; Tony Kuo; Marjan Javanbakht; Frank Sorvillo
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

8.  Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa, Ethiopia: A comparative cross-sectional study.

Authors:  Techalew Shimelis; Mekashaw Tebeje; Endale Tadesse; Belete Tegbaru; Ashenafi Terefe
Journal:  BMC Res Notes       Date:  2009-10-23

9.  High Seroprevalence of Toxoplasma gondii Antibody in HIV/AIDS Individuals from North of Iran.

Authors:  Mohammad Taghi Rahimi; Seif Ali Mahdavi; Behzad Javadian; Rozita Rezaei; Mahmood Moosazadeh; Mehri Khademlou; Seyed Hosein Seyedpour; Abolghasem Syadatpanah
Journal:  Iran J Parasitol       Date:  2015 Oct-Dec       Impact factor: 1.012

10.  Factors Associated With Toxoplasma gondii IgG and IgM Antibodies, and Placental Histopathological Changes Among Women With Spontaneous Abortion in Mwanza City, Tanzania.

Authors:  Illuminata Machumi; Mariam M Mirambo; Deodatus Ruganuza; Peter Rambau; Anthony N Massinde; Albert Kihunrwa; Stephen E Mshana; Domenica Morona
Journal:  East Afr Health Res J       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.